- Home
- TTI vs CDNA Comparison
TTI vs CDNA Comparison
Compare TTI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTI
- CDNA
- Stock Information
- Founded
- TTI 1981
- CDNA 1998
- Country
- TTI United States
- CDNA United States
- Employees
- TTI N/A
- CDNA N/A
- Industry
- TTI Oil & Gas Production
- CDNA Medical Specialities
- Sector
- TTI Energy
- CDNA Health Care
- Exchange
- TTI Nasdaq
- CDNA Nasdaq
- Market Cap
- TTI 761.0M
- CDNA 712.2M
- IPO Year
- TTI 1990
- CDNA 2014
- Fundamental
- Price
- TTI $7.70
- CDNA $18.03
- Analyst Decision
- TTI Strong Buy
- CDNA Buy
- Analyst Count
- TTI 3
- CDNA 7
- Target Price
- TTI $7.00
- CDNA $26.00
- AVG Volume (30 Days)
- TTI 2.3M
- CDNA 1.2M
- Earning Date
- TTI 10-28-2025
- CDNA 11-04-2025
- Dividend Yield
- TTI N/A
- CDNA N/A
- EPS Growth
- TTI 7085.43
- CDNA N/A
- EPS
- TTI 0.92
- CDNA 1.22
- Revenue
- TTI $618,755,000.00
- CDNA $357,998,000.00
- Revenue This Year
- TTI $5.57
- CDNA $12.73
- Revenue Next Year
- TTI $4.58
- CDNA $11.90
- P/E Ratio
- TTI $8.37
- CDNA $14.75
- Revenue Growth
- TTI 0.17
- CDNA 14.46
- 52 Week Low
- TTI $2.03
- CDNA $10.96
- 52 Week High
- TTI $8.35
- CDNA $26.37
- Technical
- Relative Strength Index (RSI)
- TTI 56.69
- CDNA 67.03
- Support Level
- TTI $7.05
- CDNA $15.60
- Resistance Level
- TTI $7.89
- CDNA $17.09
- Average True Range (ATR)
- TTI 0.51
- CDNA 1.02
- MACD
- TTI -0.08
- CDNA 0.15
- Stochastic Oscillator
- TTI 55.51
- CDNA 95.64
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.